No Data
Kaien Technology 2024 Interim Report
Kaien Technology's summary report for the first half of 2024.
Kaiyin Technology (688687.SH): the net income in the first half of the year is 42.4027 million yuan, a year-on-year growth of 10.54%.
On August 9th, Gelon Hui, Cainiao Technology (688687.SH) released its 2024 semi-annual report, achieving revenue of 0.597 billion yuan during the reporting period, a year-on-year increase of 4.89%; net income attributable to shareholders of the listed company was 42.4027 million yuan, a year-on-year increase of 10.54%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 44.6565 million yuan, a year-on-year increase of 6.84%; and the basic earnings per share was 0.25 yuan. During the reporting period, the company's operating income increased by 4.89% year-on-year, mainly due to the sales growth of Kailiwei products; net income attributable to shareholders of the listed company.
As of July 19, 2024, Kaien Technology (688687.SH) had a total of 7630 shareholders.
On July 22, Gelunhui reported that, according to the interactive platform for investors, as of July 19, 2024, Kein Technology (688687.SH) had 7,630 shareholders.
Kain Technology (688687.SH): has not yet entered the field of thrombocytosis.
On July 17, Gelun Hui reported that Kaiyin Technology (688687.SH) announced on the investor interaction platform that the company has conducted three clinical trials for different indications with Pai Yi Sheng: treatment of low-replication chronic HBV infection, shingles, and hepatic epithelioid hemangioendothelioma indications. Currently, all projects are steadily moving forward according to plan, and there is no layout of the thrombocytosis field. Please pay attention to public information for follow-up research and development of this product.
As of July 10th, 2024, there were 8047 shareholders in Kaien Technology (688687.SH) company.
On July 11th, Gelonhui reported that as of July 10th, 2024, there were 8,047 shareholders of CAIN Technology (688687.SH) according to the company's investor platform.
No Data
